You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME / ABIM MOC

Are You Up-To-Date on the Treatment of Relapsed/Refractory Mantle Cell Lymphoma? 

  • Authors: Michael Wang, MD
  • CME / ABIM MOC Released: 1/21/2021
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 1/21/2022
Start Activity


Target Audience and Goal Statement

This activity is intended for hematologists/oncologists and others involved in the care of patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL).

The goal of this activity is to improve the ability of clinicians to tailor available therapy and to increase their knowledge of novel therapies for patients with R/R MCL.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Emerging therapies for R/R MCL
  • Have greater competence related to
    • Utilizing available treatment options for patients with R/R MCL
  • Demonstrate greater confidence in their ability to
    • Understand the evolving treatment strategies in R/R MCL


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Michael Wang, MD

    The University of Texas
    MD Anderson Cancer Center
    Houston, Texas

    Disclosures

    Disclosure: Michael Wang, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AbbVie; AstraZeneca; BeiGene; Bristol Myers Squibb; Innocare; Janssen; Kite; Lily; Molecular Templates; Morehealth; Oncternal; Pharmacylics; VLS
    Served as a speaker or a member of a speakers bureau for: AbbVie; AstraZeneca; BeiGene; Bristol Myers Squibb; Innocare; Janssen; Kite; Lily; Molecular Templates; Morehealth; Oncternal; Pharmacylics; VLS
    Received grants for clinical research from: AbbVie; AstraZeneca; BeiGene; Bristol Myers Squibb; Innocare; Janssen; Kite; Lily; Molecular Templates; Morehealth; Oncternal; Pharmacylics; VLS

Editors

  • Mindy Tanzola, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Mindy Tanzola, PhD, has disclosed no relevant financial relationships.

  • Tristin Abair, PhD

    Senior Medical Writer, Medscape, LLC

    Disclosures

    Disclosure: Tristin Abair, PhD, has disclosed no relevant financial relationships.

CME/Content Reviewer

  • Robert Morris, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Robert Morris, PharmD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: ViiV Healthcare
    Owns stock, stock options, or bonds from: GlaxoSmithKline

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Are You Up-To-Date on the Treatment of Relapsed/Refractory Mantle Cell Lymphoma? 

Authors: Michael Wang, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / ABIM MOC Released: 1/21/2021

Valid for credit through: 1/21/2022

processing....

Assessment Survey

Before you begin, please take this brief survey.

  • Print